3 Major Large-Cap Stocks We Avoid
Are Large-Cap Stocks Still Worth Your Attention?
Major players in their industries, large-cap companies often have the resources to shape market dynamics. However, their vast scale can also make it difficult to sustain rapid growth, as expanding further becomes increasingly complex.
This is where StockStory steps in. Our mission is to identify resilient, high-quality businesses that can thrive in any market environment. With that in mind, let's look at three prominent large-cap stocks facing potential short-term challenges, and explore some alternative investment opportunities.
Salesforce (CRM)
Market Capitalization: $180.8 billion
Salesforce (NYSE:CRM) is a leader in cloud-based customer relationship management solutions, offering a platform that enables organizations to engage with customers across sales, service, marketing, and commerce channels.
Concerns About CRM
- Annual recurring revenue grew by just 10.3% over the past year, indicating difficulties in attracting and keeping long-term clients.
- Forecasted revenue growth of 11.1% for the upcoming year points to tepid demand.
- On a positive note, operating margins improved by 1 percentage point in the last year, reflecting some operational efficiency.
Currently, Salesforce trades at $192.25 per share, equating to a forward price-to-sales ratio of 4.
Strategy (MSTR)
Market Capitalization: $45.98 billion
Strategy (NASDAQ:MSTR), formerly focused on business intelligence software, now develops AI-driven analytics tools and is notable for its significant holdings in Bitcoin.
Why We’re Cautious About MSTR
- The company’s emphasis on Bitcoin has overshadowed its core analytics products, resulting in less innovation and fewer enterprise deals.
- Heavy reliance on debt to purchase Bitcoin exposes shareholders to heightened risks from cryptocurrency volatility and interest rate changes.
- On the upside, its large Bitcoin reserves provide Executive Chairman Michael Saylor with a unique opportunity to benefit from crypto market gains and attract investors seeking leveraged exposure to digital assets.
Strategy is priced at $137.20 per share, with a forward price-to-sales ratio of 77.
Aflac (AFL)
Market Capitalization: $58.53 billion
Recognized for its memorable duck mascot, Aflac (NYSE:AFL) specializes in supplemental health and life insurance, offering cash benefits to policyholders for costs not covered by primary insurance.
Reasons to Consider Selling AFL
- Net premiums earned have declined by 6.2% annually over the past five years, signaling weak policy sales.
- Sales are projected to fall by 1.1% over the next year, suggesting demand may become even more challenging.
- Book value per share is expected to decrease by 2.7% in the coming year, indicating potential credit quality issues.
Aflac’s current share price of $113.15 reflects a forward price-to-book ratio of 1.9.
Top Stocks That Excel in Any Market
WHILE YOU’RE HERE: Discover the 9 Best Market-Beating Stocks. The most outstanding stocks consistently outperform the market, boasting strong revenue growth, increasing free cash flow, and exceptional returns on capital. These companies have already been recognized by the market for their achievements.
Our AI-driven platform indicates that these success stories are far from over. Find out which nine stocks are leading the pack this week—completely free.
Our 2020 picks included now-household names like Nvidia (up 1,326% from June 2020 to June 2025) and lesser-known companies such as Kadant, which delivered a 351% return over five years.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OPXS Skyrockets 140% in a Year: Should You Buy the Stock?

What's Going On With Anavex Life Sciences Stock On Wednesday?
Here's Why You Should Retain Clover Stock in Your Portfolio for Now

Czech central bank marches on toward 100-ton gold reserve target, keeps Bitcoin on hold
